Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M H Silbermann

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
The Netherlands Journal of Medicine|March 30, 2011
Unusual mammary abscessM H Silbermann, J M Munneke
Nederlands Tijdschrift Voor Geneeskunde|October 3, 1992
[The phenomenon of the delayed initial attack of tertian malaria]M H Silbermann, P C Stuiver
European Journal of Cancer (Oxford, England : 1990)|March 1, 1990
Combination therapy of ACNU and ifosfamide in tumor bearing mice with M2661 breast cancer, B16 malignant melanoma or C38 colon cancerM H Silbermann, B vd Vecht, G Stoter, et al.
Nederlands Tijdschrift Voor Geneeskunde|December 2, 1995
[A patient with acute leukemia and meningitis caused by Staphylococcus epidermidis treated with fosfomycin]M H Silbermann, I C Gyssens, J J Wielenga, et al.
International Journal of Cancer|October 15, 1989
Effects of cyclosporin A and verapamil on the intracellular daunorubicin accumulation in Chinese hamster ovary cells with increasing levels of drug-resistanceM H Silbermann, A W Boersma, A L Janssen, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1997
Two patients with recurrent melioidosis after prolonged antibiotic therapyM H Silbermann, I C Gyssens, H P Endtz, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 8, 2007
[Systematic diagnosis of erythrocytosis]K de Heer, M H Silbermann, H R Koene, et al.
The Netherlands Journal of Medicine|January 8, 2014
Guideline adherence for empirical treatment of pneumonia and patient outcome. Treating pneumonia in the NetherlandsS M Huijts, C H van Werkhoven, W G Boersma, et al.
European Journal of Cancer (Oxford, England : 1990)|June 13, 2024
Quality of life gains in frail and intermediate-fit patients with multiple Myeloma: Findings from the prospective HOVON123 clinical trialM R Seefat, C A M Stege, B I Lissenberg-Witte, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The Netherlands Journal of Medicine|March 30, 2011
Unusual mammary abscessM H Silbermann, J M Munneke
Nederlands Tijdschrift Voor Geneeskunde|October 3, 1992
[The phenomenon of the delayed initial attack of tertian malaria]M H Silbermann, P C Stuiver
European Journal of Cancer (Oxford, England : 1990)|March 1, 1990
Combination therapy of ACNU and ifosfamide in tumor bearing mice with M2661 breast cancer, B16 malignant melanoma or C38 colon cancerM H Silbermann, B vd Vecht, G Stoter, et al.
Nederlands Tijdschrift Voor Geneeskunde|December 2, 1995
[A patient with acute leukemia and meningitis caused by Staphylococcus epidermidis treated with fosfomycin]M H Silbermann, I C Gyssens, J J Wielenga, et al.
International Journal of Cancer|October 15, 1989
Effects of cyclosporin A and verapamil on the intracellular daunorubicin accumulation in Chinese hamster ovary cells with increasing levels of drug-resistanceM H Silbermann, A W Boersma, A L Janssen, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1997
Two patients with recurrent melioidosis after prolonged antibiotic therapyM H Silbermann, I C Gyssens, H P Endtz, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 8, 2007
[Systematic diagnosis of erythrocytosis]K de Heer, M H Silbermann, H R Koene, et al.
The Netherlands Journal of Medicine|January 8, 2014
Guideline adherence for empirical treatment of pneumonia and patient outcome. Treating pneumonia in the NetherlandsS M Huijts, C H van Werkhoven, W G Boersma, et al.
European Journal of Cancer (Oxford, England : 1990)|June 13, 2024
Quality of life gains in frail and intermediate-fit patients with multiple Myeloma: Findings from the prospective HOVON123 clinical trialM R Seefat, C A M Stege, B I Lissenberg-Witte, et al.
Pageof 1